Steven P LaRosa MD

PubMed

• Increased Mannosylation of Extracellular Vesicles in Long COVID Plasma as a Binding Target forAgglutinin (GNA) Affinity Resin.
  Miguel A Pesqueira Sanchez, Rosalia de Necochea Campion, Thomas Dalhuisen, Emily A Fehrman, Pahul S Chhabra
  International Journal of Molecular Sciences. 2026-06-25
• Hemopurifier device in patients with solid tumours who have stable or progressive disease while on a treatment that includes pembrolizumab or nivolumab: protocol for a...
  Michael P Brown, Marco Matos, Stephen Clarke, P Toby Coates, Carol Pollock
  BMJ Open. 2026-01-05
• Increased mannosylation of extracellular vesicles in Long COVID plasma provides a potential therapeutic target foragglutinin (GNA) affinity resin.
  Miguel A Pesqueira Sanchez, Rosalia de Necochea Campion, Thomas Dalhuisen, Emily A Fehrman, Pahul S Chhabra
  Biorxiv. 2025-11-21

Journal Articles

•  
  Bernard GR, Francois B, Mira JP,Vincent JL, Dellinger RP, Russell JA, et al., Crit Care Med, 1/1/2014
• Recombinant Human Activated Protein C as a Therapy for Severe Sepsis: Lessons Learned?  
  Opal SM, LaRosa SP, Am J Respir Crit Care Med, 1/1/2013
• A Randomized, Double-Blind, Placebo-Controlled, Phase-2B Study to Evaluate the Safety and Efficacy of Recombinant Human Soluble Thrombomodulin, ART-123, in Patients wi...  
  Vincent JL, Ramesh M, Ernest D, Crit Care Med, 1/1/2013

Books/Book Chapters

• Cleveland Clinic Internal Medicine Case Reviews 
  Chapter: 59 year old diabetic man with a painful hand ulcer 
  Tabbarah K, Choueiri T, Tachopoulou O,Editors: Longworth DL, Stoller JK, Casey DM, Jewell JK.Lippincott, Williams and Wilkins, Philadelphia2003

Abstracts/Posters

• Removal of Cytomegalovirus from blood by Heparin-functional Hemoperfusion Media
  McCrea K, Ward R, 44th Critical Care Congress, Phoenix, AZ, 1/17/2015
• Real-Life Experience with Drotrecogin Alfa Activated for Severe Sepsis: An Effectiveness and Safety Meta-analysis
  Kalil AC, LaRosa SP, 40th Critical Care Congress, San Diego, CA, 1/15/2011
• Comparative Efficacy of Eritoran, a Toll-Like Receptor 4 Antagonist, in Patients with Severe Sepsis and Higher Risk of Mortality by Type of Causative Pathogen
  LaRosa SP, Tidswell MA, 40th Critical Care Congress, San Diego, CA, 1/15/2011

Lectures

• A General Review of Procalcitonin and Utilization in De-escalating Antibiotics 
  Fatima Hospital, North Providence, RI - 1/6/2014
• Severe Sepsis 
  Beverly Hospital, Beverly, MA - 1/30/2013
• Procalcitonin: Pro/Con Debate 
  San Antonio, TX - 1/9/2012

Other

• Sepsis 
  LaRosa SP, Opal SM, Scientific American Textbook of Medicine
  http://www.sciammedicine.com/sciammedicine/institutional/tableOfContent.action#
  1/1/2014